Inventor · disambiguated record
Timothy F. Briggs
Also filed as: BRIGGS TIMOTHY · BRIGGS TIMOTHY F
7 granted patents·14 pending applications·7 citations·filing 2009–2025
76Inventor score
Files withFLAGSHIP PIONEERING INNOVATIONS V INC13SENDA BIOSCIENCES INC4ENSEMBLE THERAPEUTICS CORP1LEE JINBO1RELAY THERAPEUTICS INC1
Top patents by PatentIndex Score
21 records- 0190US10953027B2Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Mar 23, 2021·3 cites·9 claims
- 0274US9284283B2Macrocyclic compounds for modulating IL-17ENSEMBLE THERAPEUTICS CORP·Filed 2013·Granted Mar 15, 2016·3 cites·16 claims
- 0374US2024180941A1Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 0472US12115178B2Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Granted Oct 15, 2024·0 cites·9 claims
- 0569US2023293458A1Multibiotic agents and methods of using the sameFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 0668US11813272B2Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Nov 14, 2023·0 cites·9 claims
- 0765US11058698B2Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Jul 13, 2021·0 cites·2 claims
- 0864US8338565B2Macrocyclic compounds for inhibition of tumor necrosis factor alphaLEE JINBO·Filed 2009·Granted Dec 25, 2012·1 cites·4 claims
- 0964US2021283157A1Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 1061US2020101030A1Multibiotic agents and methods of using the sameFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Application pending·0 cites
- 1159US2025295624A1Monomethyl fumarate-carrier conjugates and methods of their useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2025·Application pending·0 cites
- 1259US2021299079A1Monomethyl fumarate-carrier conjugates and methods of their useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 1359US2022296555A1Acylated active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
- 1459US2022296563A1Acylated active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
- 1557US2024190855A1Cdk inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1651US2021085640A1Acylated catechin polyphenols and methods of their use for the treatment of cancerFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Application pending·0 cites
- 1748US2023234917A1Asparagine derivatives and methods of using sameSENDA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1847US2023234967A1Fused Azole Heterocycles as AHR AntagonistsSENDA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1946US12162902B2Decarboxylase inhibitors for treating Parkinson's diseaseSAIL BIOMEDICINES·Filed 2019·Granted Dec 10, 2024·0 cites·19 claims
- 2044US2023295152A1Pyridopyrimidinone derivatives as ahr antagonistsSENDA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2143US2023181493A1Biomarkers related to parkinson's disease and methods of using the sameSENDA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Timothy F. Briggs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →